Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2397-2405

  Crick, Dean C ^a   Andres, Douglas A ^a   Danesi, Romano ^c   Macchia, Marco ^b   Waechter, Charles J ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Geranylgeraniol; Geranylgeranyl pyrophosphate; Lovastatin; Protein isoprenylation

Indexed keywords

MEVINOLIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL PROLIFERATION; GLIOMA; ISOPRENYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT;

ANIMALIA; MAMMALIA; OXY;

EID: 0031800322     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062397.x     Document Type: Article

References (70)

1. Agnew W. S. (1985) Squalene synthetase. Methods Enzymol. 110, 359-373.
2. Alberts A. W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., Rothrock J., Lopez M., Joshua H., Harris E., Patchett A., Monaghan R., Currie S., Stapley E., Albers-Schonberg G., Hensens O., Hirshfield J., Hoogsteen K., Liesch J., and Springer J. (1980) Mevinolin: a highly potent competitive inhibitor of hydroxymethyl-glutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77, 3957-3961.
3. Allen C. M., Kalin J. R., Sack J., and Verizzo D. (1978) CTP-dependent dolichol phosphorylation by mammalian cell homogenates. Biochemistry 17, 5020-5026.
4. Bansal V. and Vaidya S. (1994) Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes. Arch. Biochem. Biophys. 315, 393-399.
5. Baxter A., Fitzgerald B. J., Hutson J. L., McCarthy A. D., Motteram J. M., Ross B. C., Sapra M., Snowden M. A., Watson N. S., Williams R. J., and Wright C. (1992) Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. J. Biol. Chem. 267, 11705-11708.
6. Bergstrom J. D., Kurtz M. M., Rew D. J., Amend A. M., Karkas J. D., Bostedor R. G., Bansal V. S., Dufresne C., VanMiddlesworth F. L., Hensens O. D., Liesch J. M., Zink D. L., Wilson K. E., Onishi J., Milligan J. A., Bills G., Kaplan L., Omstead O. M., Jenkins R. G., Huang L., Meinz M. S., Quinn L., Burg R. W., Kong Y. L., Mochales S., Mojena M., Martin I., Pelaez F., Diez M. T., and Alberts A. W. (1993) Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90, 80-84.
7. Bhat N. R. and Volpe J. J. (1984) Relation of cholesterol to astrocytic differentiation in C-6 glial cells. J. Neurochem. 42, 1457-1463.
8. Bradfute D. L. and Simoni R. D. (1994) Non-sterol compounds that regulate cholesterogenesis. J. Biol. Chem. 269, 6645-6650.
9. Braun P. E., De Angelis D., Shytbel W. W., and Bernier L. (1991) Isoprenoid modification permits 2′,3′-cyclic nucleotide 3′-phosphodiesterase to bind to membranes. J. Neurosci. Res. 30, 540-544.
10. Burton W. A., Scher M. G., and Waechter C. J. (1979) Enzymatic phosphorylation of dolichol in central nervous tissue. J. Biol. Chem. 254, 7129-7136.
11. Casey P. J. (1994) Lipid modifications of G proteins. Curr. Opin. Cell Biol. 6, 219-225.
12. Chakrabarti R. and Engleman E. G. (1991) Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J. Biol. Chem. 266, 12216-12222.
13. Clarke S. (1992) Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu. Rev. Biochem. 61, 355-386.
14. Correll C. C., Ng L., and Edwards P. A. (1994) Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase. J. Biol. Chem. 269, 17390-17393.
15. Corsini A., Mazzotti M., Raiteri M., Soma M. R., Gabbiani G., Fumagalli R., and Paolettii R. (1993) Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 101, 117-125.
16. Crick D. C., Waechter C. J., and Andres D. A. (1994) Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells. Biochem. Biophys. Res. Commun. 205, 955-961.
17. Crick D. C., Andres D. A., and Waechter C. J. (1995a) Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells. Biochem. Biophys. Res. Commun. 211, 590-599.
18. Crick D. A., Suders J., Kluthe C. M., Andres D. A., and Waechter C. J. (1995b) Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1. J. Neurochem. 65, 1365-1373.
19. Crick D. C., Waechter C. J., and Andres D. A. (1996) Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells. SAAS Bull. Biochem. Biotech. 9, 37-42.
20. Crick D. C., Andres D. A., and Waechter C. J. (1997a) Geranylgeraniol promotes entry of UT-2 cells into the cell cycle in the absence of mevalonate. Exp. Cell Res. 231, 302-307.
21. Crick D. C., Andres D. A., and Waechter C. J. (1997b) Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation. Biochem. Biophys. Res. Commun. 237, 483-487.
22. Dunphy P. J., Kerr J. D., Pennock J. F., Whittle K. J., and Feeney J. (1967) The plurality of long chain isoprenoid (polyprenols) alcohols from natural sources. Biochim. Biophys. Acta 13, 136-147.
23. Fairbanks K. P., Witte L. D., and Goodman D. S. (1984) Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem. 259, 1546-1551.
24. Farnsworth C. C., Seabra M. C., Ericsson L. H., Gelb M. H., and Glomset J. A. (1994) Rab geranylgeranyl transferase catalyzes the geranylgeranylation of adjacent cysteines in the small GTPases Rab1A, Rab3A and Rab5A. Proc. Natl. Acad. Sci. USA 91, 11963-11967.
25. 3H]farnesol to cholesterol and cholesterogenic intermediates in the living rat eye. Biochem. Biophys. Res. Commun. 210, 695-702.
26. Goldstein J. L. and Brown M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430.
27. Grunler J., Ericsson J., and Dallner G. (1994 ) Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta 1212, 259-277.
28. Habenicht A. J. R., Glomset J. A., and Ross R. (1980) Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem. 255, 5134-5140.
29. Hancock J. F., Magee A. I., Childs J. E., and Marshall C. (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57, 1167-1177.
30. Hasumi K., Tachikawa K., Sakai K., Murakawa S., Yoshikawa N., Kumizawa S., and Endo A. (1993) Competitive inhibition of squalene synthetase by squalestatin 1. J. Antibiot. (Tokyo) 46, 689-691.
31. 1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272, 13-16.
32. Huang Z. and Poulter C. D. (1989) Stereochemical studies of botryococcene biosynthesis: analogies between 1′-1 and 1′-3 condensations in the isoprenoid pathway. J. Am. Chem. Soc. 111, 2713-2715.
33. Inoue H., Korenaga T., Sagami H., Koyama T., and Ogura K. (1994) Phosphorylation of farnesol by a cell-free system from Botryococcus braunii. Biochem. Biophys. Res. Commun. 200, 1036-1041.
34. Kamiya Y., Sakurai A., Tamura S., Takahashi N., Tsuchiya E., Abe K., and Fukui S. (1979) Structure of rhodotorucine A, a peptidyl factor, inducing mating tube formation in Rhodosporidium toruloides. Agric. Biol. Chem. 43, 363-369.
35. Keyomarsi K., Sandoval L., Band V., and Pardee A. B. (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51, 3602-3609.
36. Langan T. J. and Volpe J. J. (1986) Obligatory relationship between the sterol biosynthetic pathway and DNA synthesis and cellular proliferation in glial primary cultures. J. Neurochem. 46, 1283-1291.
37. Langan T. J. and Volpe J. J. (1987) Cell cycle-specific requirement for mevalonate, but not for cholesterol, for DNA synthesis in glial primary cultures. J. Neurochem. 49, 513-521.
38. ras. J. Biol. Chem. 265, 5157-5160.
39. Macchia M., Janitti N., Gervasi G., and Danesi R. (1996) Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins. J. Med. Chem. 39, 1352-1356.
40. Maltese W. A. (1990) Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4, 3319-3328.
41. Maltese W. A. and Sheridan K. M. (1985) Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J. Cell. Physiol. 125, 540-558.
42. Maltese W. A. and Sheridan K. M. (1987) Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell. Physiol. 133, 471-481.
43. McGuire T. F. and Sebti S. M. (1997) Geranylgeraniol potentiates lovastatin inhibition of oncogenic H-ras processing and signaling while preventing cytotoxicity. Oncogene 14, 305-312.
44. McGuire T. F., Qian Y., Vogt A., Hamilton A. D., and Sebti S. (1996) Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J. Biol. Chem. 271, 27402-27407.
45. Miegs T. E. and Simoni R. D. (1997) Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase. Arch. Biochem. Biophys. 345, 1-9.
46. Miegs T. E., Roseman D. S., and Simoni R. D. (1996) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J. Biol. Chem. 271, 7916-7922.
47. Mosley S. T., Brown M. S., Anderson R. G. W., and Goldstein J. L. (1983) Mutant clone of Chinese hamster ovary cells lacking 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 258, 13875-13881.
48. Ohizumi H., Masuda Y., Nakajo S., Sakai I., Ohsawa S., and Nakaya K. (1995) Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J. Biochem. (Tokyo) 117, 11-13.
49. Ohnuma S.-I., Watanabe M., and Nishino T. (1996) Identification and characterization of geranylgeraniol kinase and geranylgeranyl phosphate kinase from the archebacterium Sulfolobus acidocaldarius. J. Biochem. (Tokyo) 119, 541-547.
50. 1. Science 269, 1270-1272.
51. Park S. B., Howald W. N., and Cashman J. R. (1994) S-oxidative cleavage of farnesylcysteine and farnesyl cysteine methyl ester by the flavin-containing monooxygenase. Chem. Res. Toxicol. 7, 191-198.
52. Quesney-Huneeus V., Wiley M. H., and Siperstein M. D. (1979) Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA 76, 5056-5060.
53. Quesney-Huneeus V., Galick H. A., Siperstein M. D., Erickson S. K., Spencer T. A., and Nelson J. A. (1983) The dual role of mevalonate in the cell cycle. J. Biol. Chem. 258, 378-385.
54. Schafer W. R. and Rine J. (1992) Protein prenylation: genes, enzymes, targets, and functions. Annu. Rev. Genet. 30, 209-237.
55. Schmidt R. A., Glomset J. A., Wight T. N., Habenicht A. J. R., and Ross R. (1982) A study of the influence of mevalonic acid and its metabolites on the morphology of Swiss 3T3 cells. J. Cell Biol. 95, 144-153.
56. Schmidt R. A., Schneider C. J., and Glomset J. A. (1984) Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J. Biol. Chem. 259, 10175-10180.
57. Seabra M. C., Goldstein J. L., Sudhof T. C., and Brown M. S. (1992) Rab geranylgeranyl transferase: a multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or CysCys. J. Biol. Chem. 267, 14497-14503.
58. Sepp-Lorenzino L., Rao S., and Coleman P. S. (1991) Cell-cycle-dependent, differential prenylation of proteins. Eur. J. Biochem. 200, 579-590.
59. Sepp-Lorenzino L., Coleman P. S., and Larocca J. N. (1994) Isoprenylated proteins in myelin. J. Neurochem. 62, 1539-1545.
60. Sinensky M. and Logel J. (1985) Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate. Proc. Natl. Acad. Sci. USA 82, 3257-3261.
61. Sumbilla C. and Waechter C. J. (1985) Dolichol kinase, phosphatase, and esterase activity in calf brain. Methods Enzymol. 111, 471-482.
62. Symons M. (1996) Rho family GTPases: the cytoskeleton and beyond. Trends Biol. Sci. 21, 178-181.
63. Thelin A., Peterson E., Hutson J. L., McCarthy A. D., Ericcson J., and Dallner G. (1994) Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. Biochim. Biophys. Acta 1215, 245-249.
64. Vigano T., Hernandez A., Corsini A., Granata A., Belloni P., Fumagalli R., Paoletti R., and Folco G. (1995) Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation. Eur. J. Pharmacol. 291, 201-203.
65. Vogt A., Qian Y., McGuire T. F., Hamilton A. D., and Sebti S. M. (1996) Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene 13, 1991-1999.
66. Volpe J. J. and Obert K. A. (1983) Relation of cholesterol to oligodendroglial differentiation in C-6 glial cells. J. Neurochem. 40, 530-537.
67. Volpe J. J., Goldberg R. I., and Bhat N. R. (1985) Cholesterol biosynthesis and its regulation in dissociated cell cultures of fetal rat brain: developmental changes and the role of 3-hydroxy-3-methylglutaryl coenzyme reductase. J. Neurochem. 45, 536-543.
68. Waechter C. J. (1989) Biosynthesis of glycoproteins, in Neurobiology of Glycoconjugates (Margolis R. U. and Margolis R. K., eds), pp. 127-149. Plenum Press, New York.
69. Westfall D., Aboushadi N., Shackelford J. E., and Krisans S. K. (1997) Metabolism of farnesol: phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions. Biochem. Biophys. Res. Commun. 230, 562-568.
70. Zhang F. L. and Casey P. J. (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65, 241-269.